Gilead Sciences (GILD) Change in Acquisitions & Divestments (2009 - 2026)

Gilead Sciences has reported Change in Acquisitions & Divestments for 18 years, with the latest figure at $36.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $36.0 million; the trailing twelve-month figure through Mar 2026 stood at $890.0 million (up 145.92% YoY), and the FY2025 full-year result was $854.0 million, up 161.16% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $36.0 million, down from $340.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $2.3 billion in Q1 2024, with the low at -$1.9 billion in Q2 2024.
• Historically, Change in Acquisitions & Divestments has averaged $133.7 million across 5 years, with a median of $161.5 million in 2022.
• The largest YoY upside for Change in Acquisitions & Divestments was 599.07% in 2024 against a maximum downside of 27585.71% in 2024.
• Gilead Sciences' Change in Acquisitions & Divestments stood at -$820.0 million in 2022, then jumped by 42.07% to -$475.0 million in 2023, then plunged by 308.0% to -$1.9 billion in 2024, then jumped by 117.54% to $340.0 million in 2025, then tumbled by 89.41% to $36.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $36.0 million (Q1 2026), $340.0 million (Q4 2025), and $499.0 million (Q3 2025), per Business Quant data.